<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04087616</url>
  </required_header>
  <id_info>
    <org_study_id>TelAvivSMO</org_study_id>
    <nct_id>NCT04087616</nct_id>
  </id_info>
  <brief_title>Internet-based CBIT for Children With Chronic Tics</brief_title>
  <official_title>Internet-based -Guided Self-help Intervention for Children With Chronic Tics Syndrome or Tourette Syndrome: Comprehensive Behavioral Intervention for Tics (CBIT) Versus Waiting List: Reduction of Tic Severity and Quality of Life Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel Aviv Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel Aviv Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect and acceptability of an Internet-based comprehensive behavioral
      intervention for tics (ICBIT) in a sample of children and adolescents with Tic disorders.
      children and adolescents (aged 8-17 years) with Tourette Syndrome (TS) or Chronic Tic
      Disorder (CTD) and their parents will be randomly assigned to receive either an
      Internet-based ICBIT or wait-list (WL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the effect and acceptability of an Internet-based comprehensive behavioral
      intervention for tics (ICBIT) in a sample of children and adolescents with Tic disorders,
      children and adolescents (aged 8-17 years) with Tourette Syndrome (TS) or Chronic Tic
      Disorder (CTD) and their parents will be randomly assigned to receive either an
      Internet-based ICBIT or wait-list (WL) condition in a cross over design.

      Participants will be randomized to ICBIT, or to wait list, and half will cross over from wait
      list to ICBT. Two blind independent clinical evaluators will rate tic severity and
      comorbidity. The primary outcome measure is the Yale Global Tic Severity Scale (YGTSS).
      Assessments will be performed at baseline, post-ICBT or post wait list, 3-months and 6-months
      (post-treatment for those originally assigned to ICBT) and post-ICBT, 3-months and 6-months
      (post-treatment for those originally assigned to wait list condition). All assessments were
      conducted by 2 PhD level independent child psychologists.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Yale Global Tic Severity Scale (YGTSS)</measure>
    <time_frame>change from baseline YGTSS total score at 3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Tourette Syndrome in Children</condition>
  <condition>Tourette Syndrome in Adolescence</condition>
  <condition>Chronic Tic Disorder</condition>
  <arm_group>
    <arm_group_label>CBIT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICBIT. Intervention delivered through an internet platform called Managing children's' tics (www.cbteamathome.co.il), based on CBIT protocol (Woods et al., 2008) adapted to an online parent-guided self-help format.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting List</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants initially assigned to the wait list receive no psychosocial intervention for 9 weeks. Following post-WL assessment, all participants receive ICBIT.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ICBIT</intervention_name>
    <description>The intervention consists of 9 modules delivered over 9 weeks comprise of age-appropriate texts and descriptive diagrams, animations, films of clinicians demonstrating techniques such as competing response exercising.</description>
    <arm_group_label>CBIT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>waiting list</intervention_name>
    <description>Participants initially assigned to the wait list received no psychosocial intervention for 9 weeks. Following post-WL assessment, all participants chose to receive ICBIT.</description>
    <arm_group_label>Waiting List</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Tourette Syndrome or Chronic Tic Disorder.

          -  Yale Global Tic Severity Scale tic severity score â‰¥14.

        Exclusion Criteria:

          -  Change in psychotropic medication regimen during the past 6 weeks.

          -  Current diagnosis of substance abuse/dependence.

          -  Lifetime diagnosis of pervasive developmental disorder, mania or psychosis.

          -  Previous sessions of CBIT.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lilch Rachamim</last_name>
    <phone>+972528374405</phone>
    <email>lilach.rachamim7@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Rotstein, MD</last_name>
    <phone>+972524266760</phone>
    <email>michaelr@tlvmc.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>1Interdisciplinary Center (IDC)</name>
      <address>
        <city>Herzliya</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>lilach Rachamim</last_name>
      <phone>+972528374405</phone>
      <email>Lilach Rachamim &lt;lilach.rachamim7@gmail.com&gt;</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Rotstein, MD</last_name>
      <phone>+972524266760</phone>
      <email>michaelr@tlvmc.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 24, 2019</study_first_submitted>
  <study_first_submitted_qc>September 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2019</study_first_posted>
  <last_update_submitted>September 10, 2019</last_update_submitted>
  <last_update_submitted_qc>September 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tel-Aviv Sourasky Medical Center</investigator_affiliation>
    <investigator_full_name>Michael Rotstein</investigator_full_name>
    <investigator_title>Head, Pediatric Movement Disorder Clinic, Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>tics</keyword>
  <keyword>tourette Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tourette Syndrome</mesh_term>
    <mesh_term>Tic Disorders</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

